Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Serina Therapeutics
AddedFeb 15, 2024
UpdatedJun 18, 2026
Serina Therapeutics

Serina Therapeutics

Series D

Serina Therapeutics: Innovating polymer-based treatments for cancer, inflammation, pain, and metabolic disorders.

HQ
Huntsville, AL, US
Founded
2007
Overview
Compare
Fundraising
Employees
Website

Serina Therapeutics, founded with a mission to revolutionize drug delivery, focuses on developing polymer-based treatments for cancer, inflammation, pain, and metabolic disorders. Utilizing its proprietary POZ Platform™, the company offers programmable, targeted delivery of small molecules through customizable routes such as IV, SC, or IM. This technology allows for continuous drug delivery via once-weekly subcutaneous injections, aiming to enhance patient outcomes across various clinical indications.

Notable figures affiliated with Serina Therapeutics include experts in polymer science and pharmaceutical development. The company has secured investments from prominent venture capital firms and has achieved significant milestones, including clinical demonstrations of their POZ platform's safety and efficacy. Serina Therapeutics' innovative approach has the potential to significantly impact the treatment landscape for chronic and severe conditions, offering new hope for patients worldwide.

Serina Therapeutics - Similar Companies

Serpin Pharma logo

Serpin Pharma

serpinpharma.com

PanTher Therapeutics logo

PanTher Therapeutics

panthertx.com

Seres Therapeutics logo

Seres Therapeutics

Serotiny logo

Serotiny

serotiny.bio

Serenus Biotherapeutics logo

Serenus Biotherapeutics

Seranova Bio logo

Seranova Bio

seranovabio.com

SpringLeaf Therapeutics logo

SpringLeaf Therapeutics

Cytonus Therapeutics logo

Cytonus Therapeutics

cytonus.com

Seneca Therapeutics logo

Seneca Therapeutics

Juvena Therapeutics logo

Juvena Therapeutics

Traversa Therapeutics logo

Traversa Therapeutics

traversathera.com

i2o Therapeutics logo

i2o Therapeutics

i2obio.com

Therini Bio logo

Therini Bio

therinibio.com

Serinus Biosciences logo

Serinus Biosciences

serinus.bio

Seraxis logo

Seraxis

seraxis.com

Serina Therapeutics - Quick Facts

Who are Serina Therapeutics' competitors?

Companies similar to Serina Therapeutics include Serpin Pharma, PanTher Therapeutics, Seres Therapeutics and Serotiny.

When was Serina Therapeutics founded?

Serina Therapeutics was founded in 2007.

Where is Serina Therapeutics' headquarters located?

Serina Therapeutics' headquarters is located in Huntsville, AL, US.

How much has Serina Therapeutics raised to-date?

As of Aug 30, 2022, Serina Therapeutics has raised a total of $35.7M (USD).

How many employees does Serina Therapeutics have?

Serina Therapeutics has 8 employees as of Feb 5, 2024.

Serina Therapeutics - Classification

Ownership
  • Venture Capital
Technology
  • Biotech
Geographic Exposure
  • Global
Model
  • Platform
Revenue
  • Recurring
  • Software
Customer
  • Enterprise
Main Product
  • Drug Delivery
Tags
  • Healthtech
Unique IDs
  • ein: 821436829
  • secCik: 0001708599
  • ticker: SER
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8730Research, Development, And Testing Services
  • 8731Commercial Physical and Biological Research
Show 13 more industry codes
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 620000Health Care and Social Assistance
  • 325000Chemical Manufacturing
  • 623000Nursing and Residential Care Facilities
  • 325410Pharmaceutical and Medicine Manufacturing
  • 325412Pharmaceutical Preparation Manufacturing
SIC
  • 2800Chemicals And Allied Products
  • 8000Health Services
  • 2830Drugs
  • 8040Offices And Clinics Of Other Health Practitioners
  • 2834Pharmaceutical Preparations
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified